Lista de obras - Charles E Mowbray - Dominio Público Uruguay

A Concise Synthesis of Trifluoromethyl-Substituted 4-Aryloxy Pyrazoles

A Concise and Selective Synthesis of Novel 5-Aryloxyimidazole NNRTIs

artículo científico publicado en 2006

Assessment of a pretomanid analogue library for African trypanosomiasis: Hit-to-lead studies on 6-substituted 2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]thiazine 8-oxides

artículo científico publicado en 2017

Challenges of drug discovery in novel target space. The discovery and evaluation of PF-3893787: a novel histamine H4 receptor antagonist

artículo científico publicado en 2011

Comparison of the non-nucleoside reverse transcriptase inhibitor lersivirine with its pyrazole and imidazole isomers.

artículo científico publicado en 2011

Discovery of a series of potent and selective human H4 antagonists using ligand efficiency and libraries to explore structure–activity relationship (SAR)

artículo científico publicado en 2011

Discovery of a small molecule inhibitor through interference with the gp120-CD4 interaction

artículo científico publicado en 2009

Drug Discovery for Kinetoplastid Diseases: Future Directions

artículo científico publicado en 2018

Hit and lead criteria in drug discovery for infectious diseases of the developing world

artículo científico

In vitro and in vivo pharmacodynamics of three novel antileishmanial lead series.

artículo científico publicado en 2018

Lersivirine, a Nonnucleoside Reverse Transcriptase Inhibitor with Activity against Drug-Resistant Human Immunodeficiency Virus Type 1

artículo científico publicado en 2010

Novel Amino-pyrazole Ureas with Potent In Vitro and In Vivo Antileishmanial Activity

artículo científico publicado en 2015

Novel benzoxaborole, nitroimidazole and aminopyrazoles with activity against experimental cutaneous leishmaniasis

scientific article published on 26 February 2019

Novel indazole non-nucleoside reverse transcriptase inhibitors using molecular hybridization based on crystallographic overlays

artículo científico publicado en 2009

Optimization of 5-aryloxyimidazole non-nucleoside reverse transcriptase inhibitors

artículo científico publicado en 2008

Pyrazole NNRTIs 1: design and initial optimisation of a novel template

artículo científico publicado en 2009

Pyrazole NNRTIs 3: optimisation of physicochemical properties

artículo científico publicado en 2009

Pyrazole NNRTIs 4: selection of UK-453,061 (lersivirine) as a development candidate

artículo científico publicado en 2009

Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives

article

Small, non-peptide C5a receptor antagonists: Part 1

scientific article published on 31 August 2008

Small, non-peptide C5a receptor antagonists: Part 2

artículo científico publicado en 2008

Synthesis of novel histamine H4 receptor antagonists

artículo científico publicado en 2011

Treatment options for second-stage gambiense human African trypanosomiasis

artículo científico publicado en 2014

Lista de obras de Charles E Mowbray

A Concise Synthesis of Trifluoromethyl-Substituted 4-Aryloxy Pyrazoles

A Concise and Selective Synthesis of Novel 5-Aryloxyimidazole NNRTIs

Assessment of a pretomanid analogue library for African trypanosomiasis: Hit-to-lead studies on 6-substituted 2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]thiazine 8-oxides

Challenges of drug discovery in novel target space. The discovery and evaluation of PF-3893787: a novel histamine H4 receptor antagonist

Comparison of the non-nucleoside reverse transcriptase inhibitor lersivirine with its pyrazole and imidazole isomers.

Discovery of a series of potent and selective human H4 antagonists using ligand efficiency and libraries to explore structure–activity relationship (SAR)

Discovery of a small molecule inhibitor through interference with the gp120-CD4 interaction

Drug Discovery for Kinetoplastid Diseases: Future Directions

Hit and lead criteria in drug discovery for infectious diseases of the developing world

In vitro and in vivo pharmacodynamics of three novel antileishmanial lead series.

Lersivirine, a Nonnucleoside Reverse Transcriptase Inhibitor with Activity against Drug-Resistant Human Immunodeficiency Virus Type 1

Novel Amino-pyrazole Ureas with Potent In Vitro and In Vivo Antileishmanial Activity

Novel benzoxaborole, nitroimidazole and aminopyrazoles with activity against experimental cutaneous leishmaniasis

Novel indazole non-nucleoside reverse transcriptase inhibitors using molecular hybridization based on crystallographic overlays

Optimization of 5-aryloxyimidazole non-nucleoside reverse transcriptase inhibitors

Pyrazole NNRTIs 1: design and initial optimisation of a novel template

Pyrazole NNRTIs 3: optimisation of physicochemical properties

Pyrazole NNRTIs 4: selection of UK-453,061 (lersivirine) as a development candidate

Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives

Small, non-peptide C5a receptor antagonists: Part 1

Small, non-peptide C5a receptor antagonists: Part 2

Synthesis of novel histamine H4 receptor antagonists

Treatment options for second-stage gambiense human African trypanosomiasis